The combination of yondelis and cisplatin is synergistic against human tumor xenografts
2003-01-01 D'Incalci, M; Colombo, T; Ubezio, P; Nicoletti, I; Giavazzi, R; Erba, E; Ferrarese, L; Meco, D; Riccardi, R; Sessa, C; Cavallini, E; Jimeno, J; Faircloth, Gt
Trabectedin Efficacy in Ewing Sarcoma Is Greatly Increased by Combination with Anti-IGF Signaling Agents
2015-01-01 Amaral, At; Garofalo, C; Frapolli, R; Manara, Mc; Mancarella, C; Uboldi, S; Di Giandomenico, S; Ordonz, Jl; Sevillano, V; Malaguarnera, R; Picci, P; Hassan, Ab; De Alava, E; D'Incalci, M; Scotlandi, K
Phase I clinical and pharmacokinetic study of trablectedin and cisplatin in solid tumours
2009-01-01 Sessa, C; Cresta, S; Noberasco, C; Capri, G; Gallerani, E; De Braud, F; Zucchetti, M; D'Incalci, M; Locatelli, A; Marsoni, S; Corradino, I; Minoia, C; Zintl, P; Gianni, L
Ecteinascidin 743 (ET743) in ovarian cancer: activity in xenografts and preliminary results of an ongoing study in patients failing platinum-taxanes
2001-01-01 Curigliano, G; Bauer, J; Capri, G; Parma, G; Noberasco, C; Jimeno, J; Guzman, C; Sessa, C; Marsoni, S; Bartosek, A; Nicoletti, I; Giavazzi, R; D'Incalci, M
TRF2 inhibition triggers apoptosis and reduces tumourigenicity of human melanoma cells
2006-01-01 Biroccio, A; Rizzo, A; Elli, R; Koering, Ce; Belleville, A; Benassi, B; Leonetti, C; Stevens, Mfg; D'Incalci, M; Zupi, G; Gilson, E
Development and validation of a high-performance liquid chromatography-tandem mass spectrometry method for the determination of the novel inhibitor of angiogenesis E-3810 in human plasma and its application in a clinical pharmacokinetic study
2011-01-01 Sala, F; Bagnati, R; Livi, V; Cereda, R; D'Incalci, M; Zucchetti, M
E-3810, an inhibitor of the VEGF and FGF family receptors, inhibits the FGF-dependent growth of tumor cells
2010-01-01 Colella, G; Damia, G; D'Incalci, M; Cereda, R; Cavalletti, E; Spinelli, S; Camboni, G
Stepwise neoplastic transformation of a telomerase immortalized fibroblast cell line
2005-01-01 Zongaro, S; de Stanchina, E; Colombo, T; D'Incalci, M; Giulotto, E; Mondello, C
Are we close to the clinical development of novel drugs targeting telomeres and telomerase?
2005-01-01 D'Incalci, M; Zupi, G
Trabectedin in myxoid liposarcomas (MLS): a long-term analysis of a single-institution series
2009-01-01 Grosso, F; Sanfilippo, R; Virdis, E; Piovesan, C; Collini, P; Dileo, P; Morosi, C; Tercero, Jc; Jimeno, J; D'Incalci, M; Gronchi, A; Pilotti, S; Casali, Pg
IDN5109, a new taxane with oral bioavailability and antitumor activity
1999-01-01 Nicoletti, Mi; Colombo, T; Monardo, C; Rossi, C; Zucchetti, M; Bombardelli, E; Riva, A; D'Incalci, M; Giavazzi, R
Determination of Paclitaxel Distribution in Solid Tumors by Nano-Particle Assisted Laser Desorption Ionization Mass Spectrometry Imaging
2013-01-01 Morosi, L; Spinelli, P; Zucchetti, M; Pretto, F; Carra, A; D'Incalci, M; Giavazzi, R; Davoli, E
Metabolic Approach to the Enhancement of Antitumor Effect of Chemotherapy: a Key Role of Acetyl-L-Carnitine
2010-01-01 Pisano, C; Vesci, L; Milazzo, Fm; Guglielmi, Mb; Fodera, R; Barbarino, M; D'Incalci, M; Zucchetti, M; Petrangolini, G; Tortoreto, M; Perego, P; Zuco, V; Orlandi, A; Passeri, D; Carminati, P; Cavazza, C; Zunino, F
Pharmacokinetics of concomitant cisplatin and paclitaxel administered by hyperthermic intraperitoneal chemotherapy to patients with peritoneal carcinomatosis from epithelial ovarian cancer
2015-01-01 Ansaloni, L; Coccolini, F; Morosi, L; Ballerini, A; Ceresoli, M; Grosso, G; Bertoli, P; Busci, Lm; Lotti, M; Cambria, F; Pisano, M; Rossetti, D; Frigerio, L; D'Incalci, M; Zucchetti, M
Ecteinascidin-743, a new marine natural product with potent antitumor activity on human ovarian carcinoma xenografts
1998-01-01 Valoti, G; Nicoletti, Mi; Pellegrino, A; Jimeno, J; Hendriks, H; D'Incalci, M; Faircloth, G; Giavazzi, R
Antitumor and Anti-inflammatory Effects of Trabectedin on Human Myxoid Liposarcoma Cells
2010-01-01 Germano, G; Frapolli, R; Simone, M; Tavecchio, M; Erba, E; Pesce, S; Pasqualini, F; Grosso, F; Sanfilippo, R; Casali, Pg; Gronchi, A; Virdis, E; Tarantino, E; Pilotti, S; Greco, A; Nebuloni, M; Galmarini, Cm; Tercero, Jc; Mantovani, A; D'Incalci, M; Allavena, P
Telomere Damage promotes antitumoral activity of the G-quadruplex ligand RHPS4
2006-01-01 Benassi, B; Salvati, E; Leonetti, C; Rizzo, A; Mottolese, M; Stevens, M; D'Incalci, M; Gilson, E; Zupi, G; Biroccio, A
IDN 6140: A new taxane derivative exhibiting a different and favorable pharmacokinetic profile from paclitaxel
2007-01-01 Marangoni, E; Sala, F; Frapolli, R; Manzotti, C; Morazzoni, P; Tinelli, S; Ferlini, C; D'Incalci, M; Zucchetti, M
A novel taxane active against an orthotopically growing human glioma xenograft
2001-01-01 Laccabue, D; Tortoreto, M; Veneroni, S; Perego, P; Scanziani, E; Zucchetti, M; Zaffaroni, M; D'Incalci, M; Bombardelli, E; Zunino, F; Pratesi, G
Anti-inflammatory properties of the novel antitumor agent yondelis (Trabectedin): Inhibition of macrophage differentiation and cytokine production
2005-01-01 Allavena, P; Signorelli, M; Chieppa, M; Erba, E; Bianchi, G; Marchesi, F; Olimpio, Co; Bonardi, C; Garbi, A; Lissoni, A; de Brand, F; Jimeno, J; D'Incalci, M
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| The combination of yondelis and cisplatin is synergistic against human tumor xenografts | 1-gen-2003 | D'Incalci, M; Colombo, T; Ubezio, P; Nicoletti, I; Giavazzi, R; Erba, E; Ferrarese, L; Meco, D; Riccardi, R; Sessa, C; Cavallini, E; Jimeno, J; Faircloth, Gt | |
| Trabectedin Efficacy in Ewing Sarcoma Is Greatly Increased by Combination with Anti-IGF Signaling Agents | 1-gen-2015 | Amaral, At; Garofalo, C; Frapolli, R; Manara, Mc; Mancarella, C; Uboldi, S; Di Giandomenico, S; Ordonz, Jl; Sevillano, V; Malaguarnera, R; Picci, P; Hassan, Ab; De Alava, E; D'Incalci, M; Scotlandi, K | |
| Phase I clinical and pharmacokinetic study of trablectedin and cisplatin in solid tumours | 1-gen-2009 | Sessa, C; Cresta, S; Noberasco, C; Capri, G; Gallerani, E; De Braud, F; Zucchetti, M; D'Incalci, M; Locatelli, A; Marsoni, S; Corradino, I; Minoia, C; Zintl, P; Gianni, L | |
| Ecteinascidin 743 (ET743) in ovarian cancer: activity in xenografts and preliminary results of an ongoing study in patients failing platinum-taxanes | 1-gen-2001 | Curigliano, G; Bauer, J; Capri, G; Parma, G; Noberasco, C; Jimeno, J; Guzman, C; Sessa, C; Marsoni, S; Bartosek, A; Nicoletti, I; Giavazzi, R; D'Incalci, M | |
| TRF2 inhibition triggers apoptosis and reduces tumourigenicity of human melanoma cells | 1-gen-2006 | Biroccio, A; Rizzo, A; Elli, R; Koering, Ce; Belleville, A; Benassi, B; Leonetti, C; Stevens, Mfg; D'Incalci, M; Zupi, G; Gilson, E | |
| Development and validation of a high-performance liquid chromatography-tandem mass spectrometry method for the determination of the novel inhibitor of angiogenesis E-3810 in human plasma and its application in a clinical pharmacokinetic study | 1-gen-2011 | Sala, F; Bagnati, R; Livi, V; Cereda, R; D'Incalci, M; Zucchetti, M | |
| E-3810, an inhibitor of the VEGF and FGF family receptors, inhibits the FGF-dependent growth of tumor cells | 1-gen-2010 | Colella, G; Damia, G; D'Incalci, M; Cereda, R; Cavalletti, E; Spinelli, S; Camboni, G | |
| Stepwise neoplastic transformation of a telomerase immortalized fibroblast cell line | 1-gen-2005 | Zongaro, S; de Stanchina, E; Colombo, T; D'Incalci, M; Giulotto, E; Mondello, C | |
| Are we close to the clinical development of novel drugs targeting telomeres and telomerase? | 1-gen-2005 | D'Incalci, M; Zupi, G | |
| Trabectedin in myxoid liposarcomas (MLS): a long-term analysis of a single-institution series | 1-gen-2009 | Grosso, F; Sanfilippo, R; Virdis, E; Piovesan, C; Collini, P; Dileo, P; Morosi, C; Tercero, Jc; Jimeno, J; D'Incalci, M; Gronchi, A; Pilotti, S; Casali, Pg | |
| IDN5109, a new taxane with oral bioavailability and antitumor activity | 1-gen-1999 | Nicoletti, Mi; Colombo, T; Monardo, C; Rossi, C; Zucchetti, M; Bombardelli, E; Riva, A; D'Incalci, M; Giavazzi, R | |
| Determination of Paclitaxel Distribution in Solid Tumors by Nano-Particle Assisted Laser Desorption Ionization Mass Spectrometry Imaging | 1-gen-2013 | Morosi, L; Spinelli, P; Zucchetti, M; Pretto, F; Carra, A; D'Incalci, M; Giavazzi, R; Davoli, E | |
| Metabolic Approach to the Enhancement of Antitumor Effect of Chemotherapy: a Key Role of Acetyl-L-Carnitine | 1-gen-2010 | Pisano, C; Vesci, L; Milazzo, Fm; Guglielmi, Mb; Fodera, R; Barbarino, M; D'Incalci, M; Zucchetti, M; Petrangolini, G; Tortoreto, M; Perego, P; Zuco, V; Orlandi, A; Passeri, D; Carminati, P; Cavazza, C; Zunino, F | |
| Pharmacokinetics of concomitant cisplatin and paclitaxel administered by hyperthermic intraperitoneal chemotherapy to patients with peritoneal carcinomatosis from epithelial ovarian cancer | 1-gen-2015 | Ansaloni, L; Coccolini, F; Morosi, L; Ballerini, A; Ceresoli, M; Grosso, G; Bertoli, P; Busci, Lm; Lotti, M; Cambria, F; Pisano, M; Rossetti, D; Frigerio, L; D'Incalci, M; Zucchetti, M | |
| Ecteinascidin-743, a new marine natural product with potent antitumor activity on human ovarian carcinoma xenografts | 1-gen-1998 | Valoti, G; Nicoletti, Mi; Pellegrino, A; Jimeno, J; Hendriks, H; D'Incalci, M; Faircloth, G; Giavazzi, R | |
| Antitumor and Anti-inflammatory Effects of Trabectedin on Human Myxoid Liposarcoma Cells | 1-gen-2010 | Germano, G; Frapolli, R; Simone, M; Tavecchio, M; Erba, E; Pesce, S; Pasqualini, F; Grosso, F; Sanfilippo, R; Casali, Pg; Gronchi, A; Virdis, E; Tarantino, E; Pilotti, S; Greco, A; Nebuloni, M; Galmarini, Cm; Tercero, Jc; Mantovani, A; D'Incalci, M; Allavena, P | |
| Telomere Damage promotes antitumoral activity of the G-quadruplex ligand RHPS4 | 1-gen-2006 | Benassi, B; Salvati, E; Leonetti, C; Rizzo, A; Mottolese, M; Stevens, M; D'Incalci, M; Gilson, E; Zupi, G; Biroccio, A | |
| IDN 6140: A new taxane derivative exhibiting a different and favorable pharmacokinetic profile from paclitaxel | 1-gen-2007 | Marangoni, E; Sala, F; Frapolli, R; Manzotti, C; Morazzoni, P; Tinelli, S; Ferlini, C; D'Incalci, M; Zucchetti, M | |
| A novel taxane active against an orthotopically growing human glioma xenograft | 1-gen-2001 | Laccabue, D; Tortoreto, M; Veneroni, S; Perego, P; Scanziani, E; Zucchetti, M; Zaffaroni, M; D'Incalci, M; Bombardelli, E; Zunino, F; Pratesi, G | |
| Anti-inflammatory properties of the novel antitumor agent yondelis (Trabectedin): Inhibition of macrophage differentiation and cytokine production | 1-gen-2005 | Allavena, P; Signorelli, M; Chieppa, M; Erba, E; Bianchi, G; Marchesi, F; Olimpio, Co; Bonardi, C; Garbi, A; Lissoni, A; de Brand, F; Jimeno, J; D'Incalci, M |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista26919
Data di pubblicazione
- In corso di stampa6
- 2020 - 20269123
- 2010 - 201911532
- 2000 - 20094500
- 1990 - 19991429
- 1980 - 1989306
- 1975 - 197923
Editore
- Edition AERCV1
- Elsevier1
- Futura Publishing Company1
- Grafica Luigi Monti s.r.l.1
- Karger, Basel1
- Mosby1
- sn1
- Springer-Verlag1
- Thieme1
Rivista
- DIGESTIVE AND LIVER DISEASE368
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...258
- ANNALS OF ONCOLOGY243
- CANCERS228
- THE JOURNAL OF NUCLEAR MEDICINE220
- PLOS ONE212
- EUROPEAN JOURNAL OF CANCER205
- GASTROINTESTINAL ENDOSCOPY193
- JOURNAL OF CLINICAL MEDICINE184
- ALLERGY180
Keyword
- Humans2101
- Female1005
- Male964
- Middle Aged745
- Aged643
- Adult550
- COVID-19415
- Treatment Outcome359
- Animals321
- Retrospective Studies262
Lingua
- eng19197
- ita408
- spa14
- fre11
- ger8
- enm3
- por2
- chi1
Accesso al fulltext
- no fulltext24666
- reserved1362
- open891